Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lipoxin A4 (LXA4) is a lipoxygenase-derived arachidonate-like mediator with anti-inflammatory properties.Lipoxin A4 attenuates MSU crystal-induced NLRP3 inflammasome activation through inhibition of Nrf2, and regulates M1/M2 macrophage polarization through the FPR2-IRF pathway.Lipoxin inhibits oxidative stress and inflammation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 μg (283.71 µM * 250 μL in Ethanol) | $899 | In Stock |
Description | Lipoxin A4 (LXA4) is a lipoxygenase-derived arachidonate-like mediator with anti-inflammatory properties.Lipoxin A4 attenuates MSU crystal-induced NLRP3 inflammasome activation through inhibition of Nrf2, and regulates M1/M2 macrophage polarization through the FPR2-IRF pathway.Lipoxin inhibits oxidative stress and inflammation. |
In vitro | Lipoxin A4 (LXA4; NHEKs) inhibits the expression of IL-6 and IL-8, downregulates the expression of cyclin D1, and suppresses the ERK1/2 phosphorylation and NF-kB-p65 nuclear translocation in NHEKs.[2] Lipoxin A4 (100 nM; preincubation for 30 minutes; NHEKs) inhibits the NHEKs proliferation with or without stimulating by LPS (10 μg/mL).[2] Lipoxin A4 (100 nM; preincubation for 30 minutes) downregulates the LPS-induced secretion and expression of HMGB1 in keratinocytes.[1] |
Alias | LXA4 |
Molecular Weight | 352.47 |
Formula | C20H32O5 |
Cas No. | 89663-86-5 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | PBS (pH 7.2): 0.05 mg/mL H2O: < 1 mg/mL (insoluble or slightly soluble.) Ethanol: 30 mg/mL (85.11 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
Ethanol
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.